Obstetric hemorrhage risk assessment tool predicts composite maternal morbidity
Abstract Obstetric hemorrhage is one of the leading preventable causes of maternal mortality in the United States. Although hemorrhage risk-prediction models exist, there remains a gap in literature describing if these risk-prediction tools can identify composite maternal morbidity. We investigate h...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ba60975536f744a687e4c7987c2fe597 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:ba60975536f744a687e4c7987c2fe597 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:ba60975536f744a687e4c7987c2fe5972021-12-02T16:26:23ZObstetric hemorrhage risk assessment tool predicts composite maternal morbidity10.1038/s41598-021-93413-32045-2322https://doaj.org/article/ba60975536f744a687e4c7987c2fe5972021-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-93413-3https://doaj.org/toc/2045-2322Abstract Obstetric hemorrhage is one of the leading preventable causes of maternal mortality in the United States. Although hemorrhage risk-prediction models exist, there remains a gap in literature describing if these risk-prediction tools can identify composite maternal morbidity. We investigate how well an established obstetric hemorrhage risk-assessment tool predicts composite hemorrhage-associated morbidity. We conducted a retrospective cohort analysis of a multicenter database including women admitted to Labor and Delivery from 2016 to 2018, at centers implementing the Association of Women’s Health, Obstetric, and Neonatal Nurses risk assessment tool on admission. A composite morbidity score incorporated factors including obstetric hemorrhage (estimated blood loss ≥ 1000 mL), blood transfusion, or ICU admission. Out of 56,903 women, 14,803 (26%) were categorized as low-risk, 26,163 (46%) as medium-risk and 15,937 (28%) as high-risk for obstetric hemorrhage. Composite morbidity occurred at a rate of 2.2%, 8.0% and 11.9% within these groups, respectively. Medium- and high-risk groups had an increased combined risk of composite morbidity (diagnostic OR 4.58; 4.09–5.13) compared to the low-risk group. This established hemorrhage risk-assessment tool predicts clinically-relevant composite morbidity. Future randomized trials in obstetric hemorrhage can incorporate these tools for screening patients at highest risk for composite morbidity.Emer L. ColalilloAndrew D. SparksJaclyn M. PhillipsChinelo L. OnyiloforHoma K. AhmadziaNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-7 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Emer L. Colalillo Andrew D. Sparks Jaclyn M. Phillips Chinelo L. Onyilofor Homa K. Ahmadzia Obstetric hemorrhage risk assessment tool predicts composite maternal morbidity |
description |
Abstract Obstetric hemorrhage is one of the leading preventable causes of maternal mortality in the United States. Although hemorrhage risk-prediction models exist, there remains a gap in literature describing if these risk-prediction tools can identify composite maternal morbidity. We investigate how well an established obstetric hemorrhage risk-assessment tool predicts composite hemorrhage-associated morbidity. We conducted a retrospective cohort analysis of a multicenter database including women admitted to Labor and Delivery from 2016 to 2018, at centers implementing the Association of Women’s Health, Obstetric, and Neonatal Nurses risk assessment tool on admission. A composite morbidity score incorporated factors including obstetric hemorrhage (estimated blood loss ≥ 1000 mL), blood transfusion, or ICU admission. Out of 56,903 women, 14,803 (26%) were categorized as low-risk, 26,163 (46%) as medium-risk and 15,937 (28%) as high-risk for obstetric hemorrhage. Composite morbidity occurred at a rate of 2.2%, 8.0% and 11.9% within these groups, respectively. Medium- and high-risk groups had an increased combined risk of composite morbidity (diagnostic OR 4.58; 4.09–5.13) compared to the low-risk group. This established hemorrhage risk-assessment tool predicts clinically-relevant composite morbidity. Future randomized trials in obstetric hemorrhage can incorporate these tools for screening patients at highest risk for composite morbidity. |
format |
article |
author |
Emer L. Colalillo Andrew D. Sparks Jaclyn M. Phillips Chinelo L. Onyilofor Homa K. Ahmadzia |
author_facet |
Emer L. Colalillo Andrew D. Sparks Jaclyn M. Phillips Chinelo L. Onyilofor Homa K. Ahmadzia |
author_sort |
Emer L. Colalillo |
title |
Obstetric hemorrhage risk assessment tool predicts composite maternal morbidity |
title_short |
Obstetric hemorrhage risk assessment tool predicts composite maternal morbidity |
title_full |
Obstetric hemorrhage risk assessment tool predicts composite maternal morbidity |
title_fullStr |
Obstetric hemorrhage risk assessment tool predicts composite maternal morbidity |
title_full_unstemmed |
Obstetric hemorrhage risk assessment tool predicts composite maternal morbidity |
title_sort |
obstetric hemorrhage risk assessment tool predicts composite maternal morbidity |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/ba60975536f744a687e4c7987c2fe597 |
work_keys_str_mv |
AT emerlcolalillo obstetrichemorrhageriskassessmenttoolpredictscompositematernalmorbidity AT andrewdsparks obstetrichemorrhageriskassessmenttoolpredictscompositematernalmorbidity AT jaclynmphillips obstetrichemorrhageriskassessmenttoolpredictscompositematernalmorbidity AT chinelolonyilofor obstetrichemorrhageriskassessmenttoolpredictscompositematernalmorbidity AT homakahmadzia obstetrichemorrhageriskassessmenttoolpredictscompositematernalmorbidity |
_version_ |
1718384077130694656 |